Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy
- PMID: 6275162
- DOI: 10.1007/BF01720552
Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy
Abstract
We have measured the effects of digoxin on the cation transport mechanisms of patients' erythrocytes during treatment with digoxin for atrial fibrillation and cardiac failure in sinus rhythm. The results show that during short-term treatment with digoxin there is occupation of erythrocytic cardiac glycoside receptors by digoxin with resultant inhibition of active cation transport. These effects correlate well with the patients' clinical responses to treatment. During long-term treatment, however, these effects are not seen, suggesting that there is pharmacological tolerance to the effects of digoxin. The clinical implications of these results are discussed.
Similar articles
-
Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.Br J Clin Pharmacol. 1979 Aug;8(2):125-34. doi: 10.1111/j.1365-2125.1979.tb05810.x. Br J Clin Pharmacol. 1979. PMID: 486289 Free PMC article.
-
Changes in 86-rubidium uptake in erythrocytes of digoxin-treated patients, in heart failure with sinus rhythm. Relationship to clinical effects.Eur J Cardiol. 1981;12(5):275-84. Eur J Cardiol. 1981. PMID: 6265219
-
Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure.Int J Cardiol. 1990 Apr;27(1):47-53. doi: 10.1016/0167-5273(90)90190-g. Int J Cardiol. 1990. PMID: 2159446
-
Digitalis in heart failure! Still applicable?Z Kardiol. 2005 May;94(5):307-11. doi: 10.1007/s00392-005-0219-0. Z Kardiol. 2005. PMID: 15868358 Review.
-
Role of Digoxin in Atrial Fibrillation.J Pharm Pract. 2017 Aug;30(4):434-440. doi: 10.1177/0897190016642361. Epub 2016 Apr 10. J Pharm Pract. 2017. PMID: 27067743 Review.
Cited by
-
David Grahame Grahame-Smith: clinical pharmacologist. 1933-2011.Br J Clin Pharmacol. 2012 May;73(5):830-2. doi: 10.1111/j.1365-2125.2011.04160.x. Br J Clin Pharmacol. 2012. PMID: 22142441 Free PMC article. No abstract available.
-
Human skeletal muscle digitalis glycoside receptors (Na,K-ATPase)--importance during digitalization.Cardiovasc Drugs Ther. 1993 Feb;7(1):175-81. doi: 10.1007/BF00878327. Cardiovasc Drugs Ther. 1993. PMID: 8387326
-
Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.Br Heart J. 1989 Jun;61(6):529-39. doi: 10.1136/hrt.61.6.529. Br Heart J. 1989. PMID: 2503017 Free PMC article. Clinical Trial.
-
Influence of digitalis and diuretics on ouabain binding sites on human erythrocytes.Klin Wochenschr. 1984 Jan 16;62(2):87-92. doi: 10.1007/BF01769668. Klin Wochenschr. 1984. PMID: 6708393 Clinical Trial.
-
Biochemical regulators in cardiac hypertrophy.Basic Res Cardiol. 1983 Jul-Aug;78(4):351-63. doi: 10.1007/BF02070160. Basic Res Cardiol. 1983. PMID: 6226280 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical